Fecal Transplant for MDRO Decolonization
- Conditions
- Multi-antibiotic Resistance
- Interventions
- Biological: Fecal Microbiota Transplantation (FMT)
- Registration Number
- NCT04181112
- Lead Sponsor
- University of British Columbia
- Brief Summary
This is a trial designed to determine whether fecal microbiota transplantation (FMT) can eliminate highly drug-resistant bacteria from the intestinal tract of renal transplant patients. The primary goal of this study is to test whether oral gut decontamination followed by FMT using enema delivery will result in decolonization of the intestinal tract of renal transplant patients shortly after solid organ transplantation, thereby preventing difficult to treat post-transplant infections.
- Detailed Description
Contact the study principal investigator for the study protocol.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 90
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Fecal microbiota transplantation Fecal Microbiota Transplantation (FMT) - Fecal microbiota transplantation with antibiotic pre-treatment Fecal Microbiota Transplantation (FMT) -
- Primary Outcome Measures
Name Time Method The elimination of the target multi-drug resistant organism (MDRO), using culture and molecular test-based screening of recipient stool, at both the 14 and 30 days post-FMT. 3 years
- Secondary Outcome Measures
Name Time Method Compare proportions, type and timing of adverse events post-FMT 3 years Proportions of recolonization over 180 days 3 years Timing of recolonization over 180 days 3 years
Trial Locations
- Locations (2)
Vancouver Coastal Health - Vancouver General Hospital
🇨🇦Vancouver, British Columbia, Canada
Providence Health Care - St. Paul's Hospital
🇨🇦Vancouver, British Columbia, Canada